
Published November 2, 2024
Morning Report — Not Your Typical Medical Newsletter
We get it, you see a lot of medical newsletters, so hear us out. Once a month, we’ll highlight important medical news sprinkled with witty commentary, fun facts, giveaways, and more… because learning should be fun! Subscribe to receive the Morning Report directly.
Good morning! The Commonwealth of Massachusetts—home of Sam Adams, Will Hunting, marshmallow fluff, and, of course, Pri-Med—has added two Nobel laureates to its roster. Profs Gary Ruvkun of Harvard and Victor Ambros of UMass nabbed the Nobel Prize in Physiology or Medicine for their discovery of microRNA. The pair began as postdoc rivals at MIT, but in a Rocky III–like twist, forged a fortuitous friendship built on a shared passion for obscure worms. Decades ago, the duo’s fascination with the roundworm Caenorhabditis elegans unearthed microRNA, the 20-22-nucleotide molecule that regulates gene expression. What began as just a “worm thing” slowly inched its way to prominence when the discovery revealed an untapped dimension in gene regulation in humans. MicroRNA-based treatments are now in clinical trials for cancer, heart disease, and more. Props to these wicked smaht guys! |
Finding Breathing Room in O2 Therapy
PULM PONDERINGS
Current guidelines for managing severe hypoxemia recommend long-term oxygen therapy (LTOT) for a minimum of 15 hours a day, with a push for 24-hour use. Fifteen hours can be stifling, 24 downright suffocating. Is longer truly better? Given that the guidelines stemmed from two small studies published when the M*A*S*H medical team was still healing soldiers with sarcasm, it was time to answer the question with modern data.
A breath of fresh findings
In a large multicenter trial across 20 clinics in Sweden, researchers randomly assigned 241 patients with severe, chronic hypoxemia to receive LTOT for either 24 or 15 hours per day. Both groups achieved 100% adherence to their respective therapy. After one year, researchers noted no significant difference in hospitalization or mortality rates between the 24- and 15-hour groups. Also, participants reported no benefit to quality of life or fatigue symptoms with all-day oxygen use. These findings mark a shift from the four-decades-old previous studies.
Study co-leader Dr. Josefin Sundh explains, “The older studies were small and only included patients with chronic obstructive pulmonary disease, not least because it is difficult to recruit such seriously ill individuals for a randomised study. Also, the patients included in the older studies differ from those who start oxygen therapy at home nowadays.”
Key takeaways
These results suggest that all-day oxygen therapy offers no clear advantage over 15 hours of use. Those nine extra hours of freedom could provide the breathing room patients need to adhere to their LTOT, highlighting the medical wisdom that the best medicine is the one the patient will take. While the effect on mortality rates in a larger trial remains uncertain, experts believe any differences would be minimal. These findings should reassure clinicians and the one million US patients prescribed LTOT annually.
For education on pulmonary care, check out Pri-Med's CME activity “COPD Treatment for Primary Care Providers.”
Could Simple Concussion Sign Change the Game?
NEUROLOGY NEWS
A recent study presents strong data to support the inclusion of a new concussion screening indicator in official evaluation guidelines. The spontaneous headshake after a kinematic event, or “SHAAKE”—the post-blow hallmark of every pro wrestler—could alert clinicians to a probable concussion and head off the risk of missed diagnoses.
SHAAKE study
In a cross-sectional survey study, investigators at Mass General Brigham asked 347 athletes to recall instances of performing the SHAAKE in their sports careers. The investigators defined the SHAAKE as the moment after head trauma when a person “laterally shakes their head at a speed between two and eight Hertz.” Not expecting people to instinctively count Hertz, investigators used a video example to help participants identify the SHAAKE. After athletes tallied their SHAAKEs—about five on average—they linked each to their self-diagnosed concussion history. Roughly 72% of athletes, and 92% of football players, reported experiencing the SHAAKE after sustaining a concussion. The authors conclude that adding this screening tool to guidelines may help catch up to 33% of missed concussions.
Reconsidering "Tua time"
How could the SHAAKE inform gametime decisions? In one example, the researchers—playing “Monday morning quarterback”—argue that if the SHAAKE had been adopted as a concussion indicator in 2022, the NFL may have altered its controversial decision to allow Miami Dolphins quarterback Tua Tagovailoa back on the field after his (arguable) first of four pro concussions.
Key takeaways
Both sideline clinicians and cartoon fans recognize a violent headshake as the telltale residue of a hard hit, but medical literature omits this simple gesture. The study authors assert that official concussion screening protocols should reflect the predictive value of the SHAAKE, and doing so could help plug the leak of missed concussion diagnoses. Concussion expert Dr. Julie Stamm offers this perspective, “It both gives the clinician more reason to take [the athlete] off the field, and if the athlete understands that shaking their head is happening because they’re having symptoms, maybe they’ll actually realize it’s a concussion if they didn’t know that before.”
Guideline Updates
- CDC recommends lowering the age for pneumococcal vaccination from 65 to 50 years old
- Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An expert clinical consensus from the national lipid association
- New hypertension approach hits multiple targets at low dose
- ACOG updates breast cancer screening guidelines
- 2024 Guideline for the Primary Prevention of Stroke: A Guideline from the American Heart Association/American Stroke Association
New Study Points to Acupuncture for Sciatica Relief
PAIN PONDERINGS
While ancient healing practices like bloodletting and leech therapy have long rotted in the dumpster of medical history, acupuncture not only endures but also continues to target new ailments. A recent study in JAMA suggests that acupuncture may relieve sciatica pain, potentially delivering an alternative to more invasive treatments.
Acupuncture hits the mark
In a multicenter randomized clinical trial in China, researchers split 220 patients with herniated disc-related sciatica into two groups—one receiving real acupuncture, the other a sham version in which practitioners placed needles (with minimal penetration) into nontherapeutic spots. Both groups underwent ten sessions across four weeks. The true acupuncture group reported significantly faster and more substantial relief in both pain and daily functioning than did the sham group. The gap between the groups emerged by week two and persisted through follow-up at week 52. As for adverse events, the real acupuncture group had more minor effects, eg, slight bleeding, but neither reported any serious events.
A few sticking points
The trial’s limitations include the inability to blind acupuncturists (for obvious reasons), potentially introducing bias. Additionally, the findings may not generalize beyond Chinese populations, and relying on self-reported data for primary outcomes could further skew results.
Key takeaways
Previous studies have alluded to acupuncture’s potential for alleviating sciatica pain, but this trial marks the first to deliver sharp, compelling evidence in its favor. “Studies like this may facilitate the adoption of acupuncture as a form of treatment by health systems and insurers,” suggest authors of an accompanying editorial. Acupuncture may provide lasting benefits for sciatica sufferers and fill the holes left by current “unsatisfying” treatments.
|
- Oral epilepsy drug eases symptoms of OSA
- Time antihypertensives taken doesn’t matter: New trials
- Commonly used arm positions can substantially overestimate blood pressure readings
- Identifying older adults at risk for dementia based on smartphone data obtained during a wayfinding task in the real world
- New study says stronger people live longer
- Viruses are teeming on your toothbrush, showerhead
- New study debunks myths: Coffee during pregnancy safe for baby’s brain development
- FDA approves Exact Sciences’ Cologuard Plus™ test, setting a new benchmark in non-invasive colorectal cancer screening
- Bursts of exercise boost cognitive function, neuroscientists find
Morning Report is written by:
Did You Enjoy This Issue of Morning Report? Absolutely! | For the most part | Not at all Click above, or share your feedback via email. Drop us an email at morningreport@pri-med.com to let us know how we’re doing.
Please note that the summaries in Morning Report are intended to provide clinicians with a brief overview of an article, and while we do our best to select the most salient points, we ask that you please read the full article linked in each summary for clarification before making any practice-changing decisions.
Enjoying Morning Report? Share It with Colleagues! Is Morning Report for you? It is if you’re someone who needs quick-hitting, accurate medical news—but with some flair. You don’t just need to know about the latest metabolism study—you also need to know how it parallels an Alanis Morissette hit. If you’re reading about acupuncture treatment, you need us to skip the needle puns and get straight to the point. We keep things simple, but when we do get into the scientific weeds, we always remind you to check for ticks. Subscribe to receive Morning Report directly in your inbox the first Saturday of every month.
|